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Abstract: The particle size reduction of active pharmaceutical ingredients is an efficient method to
overcome challenges associated with a poor aqueous solubility. With respect to stability and patient’s
convenience, the corresponding nanosuspensions are often further processed to solid dosage forms.
In this regard, the influence of several formulation parameters (i.e., type of carrier material, type and
amount of additional polymeric drying excipient in the nanosuspension) on the redispersibility
of naproxen nanoparticle-loaded granules produced in a fluidized bed process was investigated.
The dissolution rate of the carrier material (i.e., sucrose, mannitol, or lactose) was identified as a
relevant material property, with higher dissolution rates (sucrose > mannitol > lactose) resulting in
better redispersibility of the products. Additionally, the redispersibility of the product granules was
observed to improve with increasing amounts of polymeric drying excipient in the nanosuspension.
The redispersibility was observed to qualitatively correlate with the degree of nanoparticle embedding
on the surface of the corresponding granules. This embedding was assumed to be either caused by a
partial dissolution and subsequent resolidification of the carrier surface dependent on the dissolution
rate of the carrier material or by resolidification of the dissolved polymeric drying excipient upon
drying. As the correlation between the redispersibility and the morphology of the corresponding
granules was observed for all investigated formulation parameters, it may be assumed that the
redispersibility of the nanoparticles is determined by their distance in the dried state.
Keywords: wet media milling; poor aqueous solubility; naproxen; API nanosuspension; fluidized
bed granulation; formulation parameters; reconstitution
1. Introduction
Novel potential drug candidates often exhibit a poor aqueous solubility [1,2]. Due to the fact
that this potentially compromises the bioavailability, several formulation options (e.g., salt formation,
complexation with cyclodextrins, and amorphization) have been developed in order to overcome
issues associated with poor aqueous solubility [3]. One specific option to address this is the reduction
of the particle size into the submicron size range. The underlying benefit of this approach is believed to
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be mainly driven by the increase in dissolution rate, as the latter is directly proportional to the surface
area of a compound according to the Noyes–Whitney/Nernst–Brunner equation [4–6].
Generally, nanosuspensions of active pharmaceutical ingredients (APIs) can be produced either
by bottom-up or top-down processes. During a bottom-up process, nanoparticles are formed by
precipitation of solutions. While this offers the possibility to generate amorphous nanoparticles [7,8],
downsides of this approach are that corresponding processes are often difficult to control, yield low API
concentrations, and result in related products that are challenging regarding stability and disintegration
of final dosage forms. As a result, bottom-up processes are less commonly applied compared to
so-called top-down processes [9]. Using the latter, nanoparticles are generated by mechanical particle
size reduction of coarse APIs. In this regard, wet media milling is the most frequently used top-down
method for the production of nanosuspensions in the pharmaceutical industry [9] and has been
intensively studied [10–17].
Irrespective of the route of production, API nanosuspensions present several issues concerning their
stability. Apart from potential chemical degradation and microbial contamination, nanosuspensions
are especially prone to physical stability issues. As the increase in surface area by comminution also
leads to an increase in the Gibbs free energy, nanosuspensions are thermodynamically unstable systems
tending to reduce their energy by agglomeration. Furthermore, Ostwald ripening may occur, especially
when nanosuspensions with broad particle size distributions are produced, as larger particles may
grow at the expense of smaller ones. These physical instabilities may result in an alteration of the
particle size in the suspensions and consequently in a deterioration of dissolution properties and finally
bioavailability [18]. In order to overcome these stability issues and/or to enhance patient convenience,
API nanosuspensions are often converted into solid products by suitable drying methods. To ensure
proper redispersibility of the dry products, matrix formers are often applied in order to prevent
nanoparticle agglomeration during drying [19–23].
Generally, solidification of API nanosuspensions can be achieved by well-established unit
operations. Spray-drying [7,21,24,25] and freeze-drying [20,26,27] are often described. However,
these processes have certain disadvantages concerning heat exposure and efficiency and/or often
yield products with compromised properties (e.g., flowability, particle size, hygroscopicity) towards
subsequent processing into a final dosage form.
Alternatively, API nanosuspensions can be processed in fluidized bed devices. Although the
corresponding processes normally yield products with superior properties towards subsequent
processing, e.g., into tablets [28], the number of publications regarding their applicability for
conversion of API nanosuspensions into solid products is rather low. Available literature describes
bead-coating/layering with API nanosuspensions [29–31] or the application of the corresponding
suspensions as granulation liquids in fluidized granulation processes [32–36]. Most of these studies
focus on the general feasibility of applying API nanosuspensions in the corresponding processes by
showing enhanced dissolution profiles for nanoparticle-loaded products compared to the coarse API
particles [29–36]. However, the degree of nanoparticle agglomeration during drying, typically assessed
by redispersibility studies of the dry product, was investigated only in a few studies, although it has
been shown to be an important criterion to assess the overall performance of the dried nanosuspension,
directly influencing the dissolution rate and/or bioavailability [32–34]. As a result, there is still a lack
of systematic understanding of the relationship between formulation and/or process parameters and
performance of the resulting product when using a fluidized bed process.
In this study, a nanosuspension containing naproxen was applied as a granulation liquid during
fluidized bed granulation. The influence of the applied formulation parameters on the redispersibility
of the resulting granules was of particular interest. Formulation parameters (i.e., carrier particle type,
amount and type of polymeric excipient in the nanosuspension) were systematically varied in order to
evaluate the relationship with the extent of nanoparticle agglomeration during drying. The product
performance (i.e., redispersibility) was related to the structure of the corresponding granules, enabling
a better understanding of the application of API nanosuspensions in a fluidized granulation process.
Pharmaceutics 2020, 12, 363 3 of 18
2. Materials and Methods
2.1. Materials
In this study, micronized naproxen (kindly provided by Novartis Pharma AG, Switzerland) was
used as a poorly water-soluble model API. During milling, the naproxen particles were electrosterically
stabilized against agglomeration by a combination of either vinylpyrrolidone–vinyl acetate copolymer
(PVP/VA, Kollidon VA 64, gift from BASF SE, Germany) or hydroxypropyl methyl cellulose (HPMC,
Pharmacoat 603, gift from Shin-Etsu Chemical, Japan) and sodium dodecyl sulfate (SDS, Sigma Aldrich,
USA). The stabilizers PVP/VA and HPMC were also used as additional drying excipient/matrix formers
during fluidized bed granulation.
Sucrose (Nordzucker AG, Germany), mannitol (Pearlitol 160 C, Roquette Frères, France) and
monohydrous lactose (lactose, Granulac 140, Meggle AG, Germany) were used as carrier materials in
the fluidized bed granulation process. As the applied sucrose showed a significantly different mean
particle size in comparison to mannitol and lactose, fines of sucrose were separated by air jet sieving in
order to exclude any influence of the carrier particle size on the granulation investigations. Sieving
was carried out using an e200 LS air jet sieve (Hosokawa Alpine AG, Germany). Batches of 100 g
sucrose were classified for 15 min using a 20 µm sieve at a pressure of 4000 Pa. The procedure was
repeated twice, and sieve retention was used for the granulation trials while the separated fines smaller
than 20 µm were discarded.
Characteristic properties of the carrier materials can be found in Table 1. Particle sizes and specific
surface areas were determined by laser diffraction (see Section 2.4.1) and solid densities ρsolid were
derived from gas pycnometry measurements (see Section 2.4.3).
Table 1. Characteristics of particle size distributions and specific surface areas Sm (both derived from
laser diffraction measurements), as well as solid densities ρsolid (determined by gas pycnometry) of
carrier materials used for fluidized bed granulation.
Carrier Material
X10 X50 X90 Sm ρsolid
[µm] [µm] [µm] [m2·g−1] [g·cm−3]
lactose 14.6 57.7 139.0 0.266 1.5366
mannitol 10.4 71.5 238.0 0.263 1.4839
sucrose (air jet sieved) 16.2 44.5 111.0 0.248 1.5852
If applied, water was used in bidistilled quality.
2.2. Production of Naproxen Nanosuspensions
Naproxen nanosuspensions were produced in batches of 500 g in a stirred media mill (MiniCer,
kind loan of Netzsch Feinmahltechnik GmbH, Germany). The mill was operated in recirculation mode
with a constant mass flow of about 35 kg·h−1. The stirrer tip speed was set to ν = 9 m·s−1, and the
temperature of the suspension was kept constant at 25 ± 1 ◦C at the outlet of the milling chamber.
Yttrium-stabilized zirconium oxide (ZrO2) grinding media (ρGM = 6067 kg·m−3) with a mean size of
X50,GM = 315 µm (Sigmund Lindner GmbH, Germany) were used. The filling ratio of the grinding
chamber with the grinding media was set at φGM = 0.8. Micronized naproxen particles were processed
in an aqueous suspension with a mass concentration of cm,API = 10 wt%. For stabilization, either
2.50 wt% PVP/VA or HPMC in combination with 0.25 wt% SDS was applied. To achieve a sufficiently
small particle size, the milling duration was set to 6 h.
2.3. Fluidized Bed Granulation
The milled nanosuspensions (mNS,orig. = 50 g of original suspension) were sprayed onto fluidized
carrier particles (sucrose, mannitol, lactose) in a fluidized bed device (MiniGlatt, Glatt GmbH, Germany).
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In case of the application of additional polymer (PVP/VA or HPMC), acting as binder and matrix former
to embed API nanoparticles, the corresponding amounts of these polymers were dissolved directly in
the nanosuspension prior to spraying it onto the carrier and drying the whole system in the fluidized
bed granulation process. As a result, polymer-to-API mass ratios ζ from 0.250 (original nanosuspension)
to 0.875 (PVP/VA) or 0.750 (HPMC) were obtained in the product granules. In order to keep the
theoretical API content of the granules constant, the carrier particle mass was reduced by subtracting
the corresponding amounts of additional polymer (mcarrier = 50 g for original nanosuspension). The
corresponding mass of the additional polymer in the suspension mpolymer,add., the corresponding masses
of the sprayed granulation liquid mGL, and the reduced mass of the carrier particles mcarrier,red. can be





mGL = mNS,orig. +mpolymer,add. (2)
mcarrier,red. = mcarrier −mpolymer,add. (3)
The resulting mass fractions of the carrier material cm,carrier, the polymer cm,polymer, and the API
cm,API in the product granules (neglecting minor contents of SDS) are listed in Table 2.
Table 2. Polymer to active pharmaceutical ingredient (API) ratios and resulting mass fractions of carrier









0.250 0.889 0.022 0.089
0.375 0.878 0.033 0.089
0.500 0.867 0.044 0.089
0.625 0.856 0.055 0.089
0.750 0.844 0.067 0.089
0.875 2 0.833 0.078 0.089
1 SDS was neglected; 2 only for PVP/VA.
For all granulation trials, the process parameters were kept constant. The atomizing air pressure
was set to 0.7 bar and the nanosuspension was applied with a mean feed rate of approximately
1.5 g·min−1. The inlet fluidization air was preheated to 65 ◦C and process air pressures of 0.12 to 0.30
bar were applied to maintain sufficient fluidization of the carrier particles during the process.
2.4. Characterization of Materials and Granules
2.4.1. Particle Size Measurement
Particle size of nanosuspensions (original or redispersed) was measured by means of dynamic
light scattering (DLS) with a Zetasizer nano ZSP (Malvern Panalytical Ltd., United Kingdom). Before
measurement, samples were adequately diluted with saturated and filtered (0.2 µm pore size) naproxen
solution. Diluted samples were then equilibrated for 300 s to ensure proper temperature conditioning
during measurements. Subsequently, measurements were performed at 25 ◦C for 180 s. Each sample
was measured in triplicate and the mean values of the z-average (z-avg.) and polydispersity index
(PdI) were used as characteristic values for the nanosuspensions. Prior to the measurements, the
refractive index (RI) of naproxen was determined by applying Saveyn’s multiple solvent approach [37]
at 25 ◦C and a wavelength of 589.3 nm with an Abbemat MW multiwavelength refractometer (Anton
Paar GmbH, Austria). The same device was used for the determination of the RI of the saturated
and filtered naproxen solution used as a dilution medium during measurements. The corresponding
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viscosity was determined in an Ubbelohde viscometer 52,503 (Schott-Geräte GmbH, Germany) at 25 ◦C.
In order to calculate the dynamic viscosity, the density of the dilution medium was determined with a
density meter DMA 46 (Anton Paar GmbH, Austria) at 25 ◦C.
In addition to DLS, particle sizes of redispersed suspensions were also characterized by means of
laser diffraction (LD) using a Mastersizer 3000 (Malvern Panalytical Ltd., United Kingdom) with a
Hydro MV dispersing unit. This complementary application of different particle size measurement
methods provides a more comprehensible insight into particle size distributions as in DLS large
agglomerates may sediment, withdrawing themselves from measurements, while LD does not possess
as high resolution in the nanometer range as DLS possesses. LD measurements were conducted in
saturated and filtered naproxen solution at the lowest possible stirring speed of 500 rpm in order to
prevent potential dispersion of nanoparticle agglomerates. Measurements were conducted for 20 s,
and each sample was measured in triplicate. Data evaluation was performed applying the Mie theory
using the RIs of naproxen and the dispersion medium stated above.
Particle sizes of the raw carrier materials were characterized by means of LD using a Mastersizer
3000 (Malvern Panalytical Ltd., United Kingdom) with an Aero S dispersing unit. Measurements were
conducted in triplicate with a dispersing pressure of 2.5 bar. Data evaluation was performed using
the Fraunhofer theory. Additionally, data were used to extract the specific surface areas of the carrier
materials by taking the solid densities ρsolid of the materials (see Sections 2.1 and 2.4.3) into account.
2.4.2. Redispersibility of Granules
For characterizing redispersibility of the product granules, samples were dispersed in saturated
and filtered naproxen solution on a magnetic stirrer for 15 min to facilitate complete dissolution of
the drying excipients (i.e., carrier materials, polymeric matrix former). The resulting dispersions
were measured by means of DLS (see Section 2.4.1), and mean particle size (i.e., z-avg.) and width
of the corresponding particle size distribution (i.e., PdI) were recorded. For better comparability of
different nanosuspensions, the redispersibility index (RDI) [26] was calculated by normalizing the






Furthermore, redispersed suspensions were characterized by means of LD (see Section 2.4.1) to get
a deeper understanding of the agglomeration state of the API particles, as particles coarser than about
1 µm cannot be detected reliably by means of DLS. The corresponding value in the cumulative particle
size distribution located at the transition of the submicron and the micron size range (i.e., Q3(X < 1 µm))
was used as a characteristic value referred to as the redispersed volume fraction (RVF, visualized in
Section 3.2.1, Figure 2b). The corresponding value characterizes the proportion of nanoparticles that
could be successfully redispersed from the product granules.
2.4.3. Gas Pycnometry
Solid densities ρsolid of the carrier materials were determined with a helium pycnometer Ultrapyc
1200e (Quantachrome GmbH & Co., Germany).
2.4.4. Apparent Intrinsic Dissolution Rate of Carrier Materials
Apparent intrinsic dissolution rates (IDRs) of the carrier materials were determined according to
Ph. Eur. 2.9.29 [38] with slight modifications. For this purpose, compacts of carrier materials were
produced with a compaction simulator Styl’One Evolution (MEDEL’PHARM, France) using 11.28 mm
flat-faced, round punches. Carrier compacts had a mass mcompact of 200 mg and were compacted under
adapted pressure to obtain comparable porosities εcompact calculated according to Equation (5) and
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listed in Table 3. The variables hcompact and d refer to the height and diameter of the carrier compacts,








Table 3. Porosity of carrier compacts (and corresponding standard deviations (n = 3)) used for the
determination on the apparent intrinsic dissolution rate of carrier materials according to Ph. Eur. 2.9.29.
Carrier Material εcompact[-]
sucrose 0.118 ± 0.004
mannitol 0.113 ± 0.002
lactose 0.120 ± 0.008
The carrier compact was placed in a special, self-constructed stirring device schematically depicted
in Figure 1.
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Figure 1. Schematic illustration of the stirring device for determination of the apparent intrinsic 
dissolution rate. (a) Disassembled view with 1. stirring axle, 2. bore for fixation of the cover, 3. cavity 
for carrier compact, and 4. cover for holding carrier compact in place (top view). (b) Assembled view 
with 5. filter paper, 6. carrier compact, and 7. screw for fixation of cover. 
A cellulose filter paper was placed beneath the carrier compact (i.e., at the compact–water 
interface) in order to prevent rapid disintegration and dispersion of the carrier compact. While the 
filter paper may have an impact on the dissolution rates obtained, results can be compared between 
carrier materials, as the experimental setup was identical for all experiments. However, as the 
influence of the filter paper on the IDR was not evaluated, obtained values will be referred to as the 
apparent IDRs of the carrier materials. After preparation, the stirring device with the compact was 
placed in a beaker with tempered water (25 °C) and rotated with a fixed frequency of 100 min−1. 
Samples were taken after given periods of time, and the concentration of dissolved carrier material 
was determined using an Abbemat MW multiwavelength refractometer (Anton Paar GmbH, 
Austria). 
2.4.5. Scanning Electron Microscopy 
Surface morphology of nanoparticle-loaded granules was investigated by scanning electron 
microscopy (SEM) using a Helios G4 CX (Thermo Fischer Scientific, USA). Powder samples were 
spread on double-sided adhesive carbon pads and sputtered with platinum (5 nm, EM ACE600, Leica 
Figure 1. Schematic illustration of the stirring device for determination of the apparent intrinsic
dissolution rat . ( ) Disas embled view with 1. stirring axle, 2. bore for fixation of the cover, 3. cav ty
for carrier compact, and 4. cover for holding carrie compact in place (top v ew). (b) Assembled ew
with 5. filter pa er, 6. carrier compact, and 7. sc ew f r fixatio of over.
A cellulose filter paper was placed beneath the carrier compact (i.e., at the compact–water interface)
in order to prev nt rapid disintegration and dispersion of th carrier compact. W ile the filter p per
may h ve an impact on the dissolution rates bt i ed, results can b ompared between carri r
ma ials, as the experimental se up was identical for ll experiments. However, as the influence of the
filte paper on the IDR was not evaluated, obtained values will be ref rred to as the apparent IDRs of
the carrier materials. After preparation, the stirring device with the compact was placed in a beak r
with tempered wa er (25 ◦C) and rotated with a fixed frequency of 100 m n−1. Samples were taken
after give periods of time, and the conc ntration of diss lve carrier material was determined using
an Abb mat MW multiwavelength efractomet r (Anton Paar GmbH, Austria).
2.4.5. Scanning Electron Microscopy
Surface morphology of nanoparticle-loaded granules was investigated by scanning electron
microscopy (SEM) using a Helios G4 CX (Thermo Fischer Scientific, USA). Powder samples were
spread on double-sided adhesive carbon pads an sputter d ith platinum (5 nm, EM ACE600, Leica
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Microsystems, Germany) before investigations. Afterwards, investigations were conducted with an
acceleration velocity of 2–4 kV.
2.4.6. Confocal Raman Microscopy
In order to evaluate the thickness of API-containing layers on the product granules, confocal
Raman microscopy was chosen, as it is capable of identifying chemical compounds in microscopic
dimensions in three-dimensional volumes. It was conducted using an Alpha 300R microscope (WITec
GmbH, Germany) with an excitation wavelength of 532 nm, operated at a laser power of approximately
5.4 mW and an integration time of 0.1 s. Depth scans of the granules with a size of 10 µm × 10 µm
were performed with a step size of 0.2 µm using 100-fold magnification. The data were postprocessed
using cosmic ray removal, noise filtering and background subtraction. Afterwards, datasets were
compared with reference data of pure naproxen and carrier materials in order to visualize the naproxen
distribution in a Raman chemical map.
3. Results and Discussion
3.1. Production of Naproxen Nanosuspensions
Wet media milling yielded nanosuspensions of naproxen meeting the quality criteria of a z-avg.
below 250 nm and a PdI below 0.2, as defined by Bitterlich et al. [14]. Data in Table 4 (standard
deviations were below 2 nm for the z-avg. and 0.01 for the PdI) indicate that both applied stabilizers
yielded nanosuspensions with similar particle size properties (i.e., z-avg. and PdI) after 6 h of wet
media milling. However, both suspensions show certain instabilities, as indicated by an increase
in the particle size and/or the PdI upon storage at ambient temperatures. A fairly rapid increase in
particle size could be observed during the first 3 days of storage (approximately 11% for PVP/VA,
approximately 8% for HPMC), followed by much less pronounced increases between 3 and 7 days
of storage (approximately 5% for PVP/VA, approximately 2% for HPMC). Therefore, subsequent
nanosuspension drying experiments were conducted within 3 to 7 days after production of the
nanosuspension to exclude any influence of the particle size during the subsequent drying process.
Table 4. Particle size (i.e., z-average) and PdI of the naproxen nanosuspensions directly after milling
and after storage at ambient conditions.
Stabilizers
After Milling 3 Days of Storage 7 Days of Storage
z-avg. PdI z-avg. PdI z-avg. PdI
[nm] [-] [nm] [-] [nm] [-]
2.50 wt% PVP/VA
+ 0.25 wt% SDS 132.7 0.13 147.5 0.13 154.1 0.11
2.50 wt% HPMC +
0.25 wt% SDS 141.6 0.12 153.2 0.14 155.9 0.14
3.2. Fluidized Bed Granulation of Naproxen Nanosuspensions
For the fluidized bed granulation experiments, API contents of 8.87 wt% (theoretical) naproxen
were targeted in the granules. Although corresponding experiments led to differences in process yield
and naproxen content of the granules, these differences were not further investigated, as yields were
over 80%, and deviations of obtained versus theoretical API contents were all below 10% (data not
shown). As no systematic variations of these properties for the different formulation parameters were
observed, differences were attributed to common process and analytical fluctuations. However, the
main focus of the study lies on the influence of the investigated formulation parameters on the particle
size of naproxen after the drying process (i.e., redispersibility). Although the dissolution rate and
content uniformity of the API are important properties for the final characterization of the process, the
redispersibility is a preliminary quality indicator for the products and the first step towards finally
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improved bioavailability. In this regard, it has to be noted that only the steady state redispersibility after
a sufficient duration of redispersion (see Section 2.4.2) was investigated, neglecting possible differences
in the suspension reformation process. However, these differences were assumed to be marginal based
on the similar formulations and steady state particle sizes after redispersion are assumed to give valuable
information to fundamentally understand the present process. In this context, it has to be additionally
noted that fluidized granulation experiments were conducted only once for each formulation in this
study. However, in a preliminary study, the reproducibility concerning the redispersibility of the
nanoparticle-loaded granules was investigated and considered to be sufficient. Standard deviations
of the characteristics for redispersibility were below 0.05 for the RDI obtained by DLS and below 5%
for the RVF obtained by LD for three separately produced batches of nanoparticle-loaded granules.
Additionally, redispersibility of granules was observed to be insusceptible to minor fluctuations of
process parameters.
3.2.1. Influence of Carrier Material
In order to investigate the influence of the carrier material on the redispersibility of naproxen
nanoparticles from the dry products, nanosuspensions without additional drying excipients (except
the stabilizer, i.e., PVP/VA) were applied to fluidized carrier particles. Data obtained from the
redispersibility studies are shown in Figure 2.
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Figure 2. Influence of the carrier particle type on the redispersibility of granules produced with
a naproxen nanosuspension without additional drying excipients (except the stabilizing polymer
PVP/VA). Measurements ere carried out by eans of (a) LS and (b) L (dashed lines refer to
extracted redispersed volume factions).
Data suggest articles were at least partially reconstitutable from the granules for
all investigated carrier materials, although no further drying excipient/matrix material besides the
stabilizers in the nanosuspensions as applie . o ever, distinct differences can be observed
depending on the car ier material use . t ri l, r ispersibility was rather
po r, as indicated by an RDI of 1.37 an a el . li tion of annitol as a ca rier
material resulted in a less co ro ise rti l l of 1.18 and RVF of nearly
0.9. Finally, sucrose sho ed the st lt , it l t t r early co pletely redispersible
to the originally applied nanosuspensio s s i i t I f rl . .
Data ad itionally reveal that both measurement techniques result in similar conclusions regarding
the redispersibility of the samples. An increase in RDI and PdI obtained from DLS measurements always
correlates with a reduced RVF extracted from LD measurement data. However, both measurement
techniques have their advantages and disadvantages. Measurements by means of DLS offer the
possibility to accurately measure the particle size in the submicron range, but particles larger than
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1 µm cannot be measured reliably. Furthermore, corresponding particles may sediment during
measurements, as measurements are carried out in cuvettes under the avoidance of any convective
flow due to the measurement principle. The latter drawback is not relevant during LD measurements
that are carried out under constant circulation of the sample through a measurement cell. Furthermore,
LD measurements with the present device (see Section 2.4.1) are applicable over a wide size range
enabling the concomitant detection of redispersed nanoparticles and micron-sized agglomerates.
However, here coarser particles tend to superimpose smaller particles due to their higher scattering
intensity. Therefore, the combination of both measurement techniques is deemed necessary for in-depth
evaluation of redispersibility.
To elucidate the influence of the carrier material on the redispersibility in more detail, surface
morphologies of the corresponding granules were investigated by means of SEM (Figure 3).
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within the surface of the granules can be assumed to be caused y properties of the carrier particl s.
B sed on the SEM data obtaine nd its correlation with redispersibility results, our hypothesis is that
partial dissolution of the carrier material oc urs at the particle surf ce upon droplet impingement and
that subsequent resolidification of the dissolved fractions causes embedding nd s paration of the
API p rticles. Would this hypothesis hold, differences in the dissolution rates of the different carrier
mat rials should correlate to the ifferences in nanoparticle mbedding nd finally redispersibility. As
a fluidized bed granulation process is a dyn mic proces of wetting of the fluidized carrier particles
and drying of the granulation liquid, contact between a single dr plet and carrier particle, as well as
resulting dissolution of the rface, are assumed to occur in short period of time. Therefore, one
would exp ct that the dissolution rate of t e carrier needs to be high in ord r to result in effective
nanoparticl embedding and separation. Apparent IDRs of the c rier materials we e determined
based on the procedure of Ph. Eu . 2.9.29 [38]. Results are depicted in Figure 4. Thes were linearly
fitt d in o der to extract the appar nt IDR, i.e., the amount of material that dissolves per unit of area
and time.
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the apparent intrinsic dissolution rates of the carrier materials were derived as the slope of the
regression line.
Generally, it can be seen that the dissolution curves of the carrier materials can be well-fitted
(R2 > 0.95), and the resulting apparent IDRs increased in the order lactose < mannitol < sucrose
(Table 5).
Table 5. Apparent intrinsic dissolution rates (IDRs), corresponding standard deviations and R2 of
linear fits of intrinsic dissolution data determined according to Ph. Eur. 2.9.29 (with modifications) for
the different carrier materials (n = 3).




sucrose 1.623 ± 0.062 0.994
mannitol 0.640 ± 0.029 0.992
lactose 0.290 ± 0.031 0.956
Plotting results from the redispersibility studies (i.e., RDI and RVF) for the different carrier
materials against the corresponding apparent IDR indicates that the redispersibility of the granules
actually improves with increasing apparent IDR of the carrier materials (Figure 5). This is seen
as a proof for our hypothesis that faster dissolution of the carrier particle surface material upon
droplet impingement, as indicated by the apparent IDR values, results in more extensive API particle
embedding in the carrier material upon resolidification, finally yielding superior redispersibility of
the nanoparticles.
The fact that carrier materials with higher dissolution rates lead to a higher redispersibility of
nanosuspensions dried in a fluidized granulation process was already observed by Bose et al. [35].
In that study, investigations were conducted with mannitol and lactose, and effects on the dissolution
rate of a poorly soluble API were compared. The authors related their investigations to a specific
interaction between the carrier particles and the API and/or errors during analytical investigations and
did not further discuss or investigate their findings [35]. However, a higher solubility of excipients was
observed by Jaiyeoba and Spring to result in coarser and stronger granules during wet granulation
processes. This observation was related to a dissolution and subsequent resolidification of the
corresponding excipients during granulation, resulting in an increased number of solid bridges
between the corresponding particles [39]. These observations are in line with the experimental findings
and hypothesis of our own study mentioned above.
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the redispersibility (i.e., RDI a d RVF) of granules produced with a naproxen nanosuspe sion
(stabilized with PVP/VA) without additional drying excipient a d differe t carrier materials (lactose,
mannitol, sucrose).
A potential alternative cause for differences in redispersibility found in the literature is the size
of the carrier m terial. Azad et al. observed higher dissolution rates and bett
API nanosu pensions applied to smaller lactose carri r particles in a fluidiz granulation process.
The authors attributed these findi gs to ifferences i he thicknes of the API-loaded film around
the carrier particles caused by differences in the specific su face area of the different lactose grades.
Although no further dis ussion of how this film thickness may influence the red spersibility of the
nanoparticle-loaded gran les was provided [32], it may be assumed that the carrier partic e size
determines the total accessible cont ct area between the droplet of the API nanosuspen ion a d the
carrier material, changing the amounts of ca rier material that d ssolve and ubs quently resolidify
during th granulation roce s. As such, smaller carrier particles with a higher specific surface
area might cause a higher degree of nanoparticl embedding and separation, resulting in a bet er
redispersibility. Al ough we tried to adjust particle sizes by choice of materials and additional air jet
sieving of sucrose in the pr sent study, th re w re still ifferences in the mean particle sizes (∆X50,max
= 27.0 µm, see Table 1 in Section 2.1) and, consequently, specific surface area of the ca r er materials.
However, as n systematic dependence of th redispersibility on the part cle size and/or specific urfac
rea f the carri r materials was found, the findings of Azad et al. cannot directly be confirmed. This
might be t ributed to the fact that the difference in particle size w s much igher (∆X50,max = 293.4 µm)
in e corresponding study [32]. Whether and how both investigated phenomena (influence of particl
size/spec fic surface area and influence of the dissolution rate of th carrier material) superimpos
mand fur r investigations.
As it can be assumed that differences in surface t i dissoluti n and subsequent resolidification
granulation will also result in differences in the thickness of the nanoparticle-loaded l y r
around the carrier pa ticles, tw -dimensiona (x-z) chemical mapping depth scans of the granul s
surfac s were recorded by confocal Raman micros opy (Figure 6).
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Figure 7. Effect of additional polymer (PVP/VA) in the granulation fluid on the redispersibility of 
granules produced with different carrier materials (lactose, mannitol, sucrose). Measurement of 
redispersed suspensions was carried out by means of (a) DLS and (b) LD. 
For mannitol and lactose, for which no complete redispersibility was achieved after applying a 
pure nanosuspension, the redispersibility improved with increasing amount of additional polymer 
in the nanosuspensions (i.e., ratio polymer / API). For sucrose as a carrier material, granules were 
completely redispersible irrespective of the amount of additional polymer in the granulation liquid. 
Furthermore, data clarify that the amount of additional polymer in the nanosuspension required to 
obtain complete redispersibility is dependent on the applied carrier material and correlates with the 
redispersibility when a nanosuspension without additional polymeric drying excipient/matrix 
material is applied. While both datasets point towards the same trends, slightly different points of 
‘complete redispersibility’ can be identified for the different carrier materials depending on the 
technique used. Whereas results obtained with DLS indicate that granules of mannitol and lactose 
were completely redispersible for polymer-to-API ratios of 0.625 and 0.875, respectively, data 
obtained by LD suggest the corresponding granules to be completely redispersible at lower polymer-
to-API ratios of 0.500 (mannitol) and 0.750 (lactose). This indicates that a complete redispersion into 
a nanosuspension (as indicated by an RVF of 1) does not necessarily exclude an increase of the particle 
size of naproxen during drying (e.g., by agglomeration of single nanoparticles). However, in the 
current study, an RDI below 1.10 obtained from DLS measurements was always in accordance with 
a complete redispersion to a nanosuspension, as indicated by data obtained from LD measurements. 
The corresponding size increase of 10% of the naproxen particles upon drying is regarded as 
acceptable. Nevertheless, results emphasize the necessity of using both measurement techniques in 
order to prevent false conclusions regarding the redispersibility of dried nanosuspensions. 
For visualization of the influence of the additional polymer in the nanosuspension, SEM images 
of surfaces of granules produced with lactose as a carrier material and nanosuspensions with 
different amounts of additional polymer (i.e., PVP/VA) are presented in Figure 8. 
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Furthermore, data clarify that the amount of additional polymer in the nanosuspension required to
obtain complete redispersibility is dependent on the applied carrier material and correlates with the
redispersibility when a nanosuspension without additional polymeric drying excipient/matrix material
is applied. While both datasets point towards the same trends, slightly different points of ‘complete
redispersibility’ can be identified for the different carrier materials depending on the technique used.
Whereas results obtained with DLS indicate that granules of mannitol and lactose were completely
redispersible for polymer-to-API ratios of 0.625 and 0.875, respectively, data obtained by LD suggest
the corresponding granules to be completely redispersible at lower polymer-to-API ratios of 0.500
(mannitol) and 0.750 (lactose). This indicates that a complete redispersion into a nanosuspension (as
indicated by an RVF of 1) does not necessarily exclude an increase of the particle size of naproxen
during drying (e.g., by agglomeration of single nanoparticles). However, in the current study, an RDI
below 1.10 obtained from DLS measurements was always in accordance with a complete redispersion
to a nanosuspension, as indicated by data obtained from LD measurements. The corresponding size
increase of 10% of the naproxen particles upon drying is regarded as acceptable. Nevertheless, results
emphasize the necessity of using both measurement techniques in order to prevent false conclusions
regarding the redispersibility of dried nanosuspensions.
For visualization of the influence of the additional polymer in the nanosuspension, SEM images
of surfaces of granules produced with lactose as a carrier material and nanosuspensions with different
amounts of additional polymer (i.e., PVP/VA) are presented in Figure 8.
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The degree of nanoparticle embedding on the surface of the granules increased with increasing
amounts of additional polymer in the nanosuspension. As the redispersibility of the corresponding
granules also improved with increasing amounts of polymer, the hypothesis that an embedding of
the nanoparticles in a matrix prevents agglomeration during drying and facilitates redispersion can
be confirmed. The fact that increasing drying excipient to API ratios improves redispersibility for
granules obtained in a fluidized bed process was also observed by Azad et al. [32]. However, they
did not attempt to correlate redispersibility to the morphology of the corresponding dried products.
Although Melzig et al. investigated a different process by spray-drying nanosuspensions of amorphous
ibuprofen nanoparticles, results obtained have relevance to the current study. The authors observed
insufficient redispersibility of samples when nanoparticles were not completely embedded within a
matrix and related this to an insufficient nanoparticle distance in the granules resulting in increased
interactions between the nanoparticles [7]. This argumentation is relevant to the current study and will
be further discussed in Section 4.
3.2.3. Influence of Polymer Type in the Nanosuspension
Finally, the influence of the applied polymer in the nanosuspension on redispersibility was a
further point of interest. Therefore, a naproxen nanosuspension stabilized with HPMC instead of
PVP/VA was prepared and sprayed onto different fluidized carrier particles (i.e., lactose, mannitol,
sucrose) at different polymer-to-API ratios. An influence of the particle size of the naproxen can be
Pharmaceutics 2020, 12, 363 14 of 18
excluded, since the formulations with the two different stabilizer regimes yielded nanosuspensions
with comparable particle size distributions, as discussed in Section 3.1 (Table 4). Results from the
corresponding redispersibility studies are depicted in Figure 9.
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The fact that this size increase with increasing polymer concentrations was not observed when PVP/VA
was applied may be attributed to the fact that HPMC yields higher viscosities than vinylpyrrolidones
in comparable concentrations [41]. For lactose, application of a nanosuspension without additional
polymeric drying excipient (i.e., polymer-to-API ratio of 0.25) resulted in a slightly compromised
particle size of the redispersed suspension, as indicated by an RDI of 1.13. However, complete
redispersibility could be achieved with only minor amounts of additional polymer. In comparison with
the nanosuspension stabilized with the PVP/VA copolymer, application of HPMC as a stabilizer in the
nanosuspension resulted in a better redispersibility of the granules for all carrier materials at a given
polymer concentration. Consequently, polymer consumption to achieve complete redispersibility
can be reduced by the factor of up to 2 when HPMC is used as a polymeric drying excipient instead
of PVP/VA.
Surface morphology of granules produced with a pure nanosuspension stabilized by HPMC
(Figure 10) reveals high degrees of nanoparticle embedding within the surface of the granules,
irrespective of the applied carrier particle type. Consequently, a high degree of nanoparticle embedding
qualitatively correlates with a good redispersibility, as seen in previous sections.
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Figure 11. Comparative depth scans conducted by confocal Raman microscopy of granules produced
with a naproxen (yellow false color according to reference spectra) nanosuspension stabilized with
PVP/VA or HPMC without additional drying excipient and with lactose (green false color according to
reference spectra) carrier particles.
4. Conclusions
Preservation of redispersibility is a key objective during the conversion of API nanosuspensions
into the solid state in order to maintain the advantageous properties of the nanoparticles with regard to
Pharmaceutics 2020, 12, 363 16 of 18
bioavailability of the API. The results of this study underline the importance of adapting formulation
parameters during application of a naproxen nanosuspension in a fluidized bed process in order to
prevent agglomeration of nanoparticles. Furthermore, irrespective of the applied formulation, the
redispersibility of the product granules was observed to qualitatively correlate with the degree of
nanoparticle embedding within the surface of the corresponding granules. Additionally, Raman
chemical maps qualitatively revealed differences in the thickness of nanoparticle-loaded layers around
the carrier particles for selected formulation parameters (i.e., carrier particle type, type of polymer in the
nanosuspension). The dissolution rate of the carrier material and the type of the polymer were identified
as the determining factors for layer thickness. Irrespective of the cause for observed differences in
the degree of nanoparticle embedding, this embedding can be directly attributed to the dispersion
of the naproxen nanoparticles in a carrier/polymer matrix and finally to different distances between
individual nanoparticles. According to Melzig et al. [7], an insufficient separation of nanoparticles and,
consequently, low distances between individual particles may result in higher potential of interaction,
finally causing nanoparticle agglomeration and a poor redispersibility. On the other hand, better
separation of the particles and corresponding larger distances between individual nanoparticles may
prevent an agglomeration and result in a preservation of redispersibility. Consequently, it may be
assumed that the redispersibility of a dried nanosuspension is determined by the distances between
the API nanoparticles in the dry state. However, while this study rather gives a qualitative correlation
between the redispersibility of the products and the dispersion of the naproxen nanoparticles in a
carrier/polymer matrix, a theoretical or exemplary description of these relationships, following the
example of Steiner et al. [40], may enable a prediction of the formulation design for producing API
nanoparticle-loaded granules with predefined properties. In this regard, the results presented in
this study identify crucial formulation parameters during drying of naproxen nanosuspensions in a
fluidized bed process and hint to the underlying mechanism for the preservation of redispersibility of
the corresponding products
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